follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Everett Laboratories acquires Quinnova Pharmaceuticals

By

Back to Top Comments Email Print

Latest News

advertisement

Chatham-based Everett Laboraties Inc., a subsidiary of Spain-based Exeltis, announced Monday its acquisition of Quinnova Pharmaceuticals from Bridgewater-based Aneal Enterprises LLC. Terms of the deal were not disclosed.

According to the announcement, the acquisition will result in the strategic expansion of Everett into the fast-growing U.S. dermatology market. As a member of the Exeltis family, the acquisition will allow Quinnova to leverage extensive resources and capabilities in research and development, marketing strategy, intellectual property and business development worldwide. This broad-based support will enable Quinnova to be positioned to accelerate growth and development of its product portfolio and development pipeline.


Stay informed: Subscribe to free NJBIZ newsletters

 
 

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top